Literature DB >> 15564450

Identification of a naturally processed cytotoxic CD8 T-cell epitope of coxsackievirus B4, presented by HLA-A2.1 and located in the PEVKEK region of the P2C nonstructural protein.

Ruben Varela-Calvino1, Ania Skowera, Sefina Arif, Mark Peakman.   

Abstract

The adaptive immune system generates CD8 cytotoxic T lymphocytes (CTLs) as a major component of the protective response against viruses. Knowledge regarding the nature of the peptide sequences presented by HLA class I molecules and recognized by CTLs is thus important for understanding host-pathogen interactions. In this study, we focused on identification of a CTL epitope generated from coxsackievirus B4 (CVB4), a member of the enterovirus group responsible for several inflammatory diseases in humans and often implicated in the triggering and/or acceleration of the autoimmune disease type 1 diabetes. We identified a 9-mer peptide epitope that can be generated from the P2C nonstructural protein of CVB4 (P2C(1137-1145)) and from whole virus by antigen-presenting cells and presented by HLA-A2.1. This epitope is recognized by effector memory (gamma interferon [IFN-gamma]-producing) CD8 T cells in the peripheral blood at a frequency of responders that suggests that it is a major focus of the anti-CVB4 response. Short-term CD8 T-cell lines generated against P2C(1137-1145) are cytotoxic against peptide-loaded target cells. Of particular interest, the epitope lies within a region of viral homology with the diabetes-related autoantigen, glutamic acid decarboxylase-65 (GAD(65)). However, P2C(1137-1145)-specific cytotoxic T lymphocyte (CTL) lines were not activated to produce IFN-gamma by the GAD(65) peptide homologue and did not show cytotoxic activity in the presence of appropriately labeled targets. These results describe the first CD8 T-cell epitope of CVB4 that will prove useful in the study of CVB4-associated disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564450      PMCID: PMC533958          DOI: 10.1128/JVI.78.24.13399-13408.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Population of the HLA ligand database.

Authors:  M Sathiamurthy; H D Hickman; J W Cavett; A Zahoor; K Prilliman; S Metcalf; M Fernandez Vina; W H Hildebrand
Journal:  Tissue Antigens       Date:  2003-01

Review 2.  Cellular mechanisms governing cross-presentation of exogenous antigens.

Authors:  Anne L Ackerman; Peter Cresswell
Journal:  Nat Immunol       Date:  2004-07       Impact factor: 25.606

3.  A structural basis for immunodominant human T cell receptor recognition.

Authors:  Guillaume B E Stewart-Jones; Andrew J McMichael; John I Bell; David I Stuart; E Yvonne Jones
Journal:  Nat Immunol       Date:  2003-06-08       Impact factor: 25.606

4.  Isolation of a virus from the pancreas of a child with diabetic ketoacidosis.

Authors:  J W Yoon; M Austin; T Onodera; A L Notkins
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

5.  Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child.

Authors:  L E Davis; D Bodian; D Price; I J Butler; J H Vickers
Journal:  N Engl J Med       Date:  1977-08-04       Impact factor: 91.245

6.  Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice.

Authors:  Michele P Marron; Robert T Graser; Harold D Chapman; David V Serreze
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-02       Impact factor: 11.205

7.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

Authors:  G F Bottazzo; B M Dean; J M McNally; E H MacKay; P G Swift; D R Gamble
Journal:  N Engl J Med       Date:  1985-08-08       Impact factor: 91.245

8.  Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.

Authors:  Simon F Lacey; Maria C Villacres; Corinna La Rosa; Zhongde Wang; Jeff Longmate; Joybelle Martinez; John C Brewer; Shahram Mekhoubad; Rebecca Maas; John M Leedom; Stephen J Forman; John A Zaia; Don J Diamond
Journal:  Hum Immunol       Date:  2003-04       Impact factor: 2.850

9.  Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality.

Authors:  E Halliday; J Winkelstein; A D B Webster
Journal:  J Infect       Date:  2003-01       Impact factor: 6.072

10.  Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.

Authors:  Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

View more
  9 in total

Review 1.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

Review 2.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

3.  POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction.

Authors:  Qingqing Meng; Yahong Wu; Xinghua Sui; Jingjie Meng; Tingting Wang; Yan Lin; Zhiwei Wang; Xiuman Zhou; Yuanming Qi; Jiangfeng Du; Yanfeng Gao
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

4.  Wild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivo.

Authors:  Christopher C Kemball; Claudia T Flynn; Martin P Hosking; Jason Botten; J Lindsay Whitton
Journal:  Virology       Date:  2012-05-01       Impact factor: 3.616

5.  HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.

Authors:  Richard J Ellis; Ruben Varela-Calvino; Timothy I M Tree; Mark Peakman
Journal:  Immunology       Date:  2005-11       Impact factor: 7.397

6.  In silico and ex vivo approaches indicate immune pressure on capsid and non-capsid regions of coxsackie B viruses in the human system.

Authors:  Rhiannon Kundu; Robin Knight; Meenakshi Dunga; Mark Peakman
Journal:  PLoS One       Date:  2018-06-20       Impact factor: 3.240

7.  Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes.

Authors:  Cristina Calviño-Sampedro; Iria Gomez-Tourino; Oscar J Cordero; Pedro A Reche; Marta Gómez-Perosanz; Jose Luis Sánchez-Trincado; Miguel Ángel Rodríguez; Aurelio M Sueiro; Juan E Viñuela; Rubén Varela Calviño
Journal:  FASEB J       Date:  2019-02-28       Impact factor: 5.191

8.  Precise genotyping and recombination detection of Enterovirus.

Authors:  Chieh-Hua Lin; Yu-Bin Wang; Shu-Hwa Chen; Chao Agnes Hsiung; Chung-Yen Lin
Journal:  BMC Genomics       Date:  2015-12-09       Impact factor: 3.969

9.  Potential Mimicry of Viral and Pancreatic β Cell Antigens Through Non-Spliced and cis-Spliced Zwitter Epitope Candidates in Type 1 Diabetes.

Authors:  Michele Mishto; Artem Mansurkhodzhaev; Teresa Rodriguez-Calvo; Juliane Liepe
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.